RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

SMILES:

CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)…

InChI Key:

PNDKCRDVVKJPKG-WHERJAGFSA-N

ClinicalTrials.gov PubMed

Clinical Development by Virus4

Human immunodeficiency virus 1

HIV-1

Target: Human CCR5

Phase 2

Preclinical

Phase 2

Phase 3

Approved

Human immunodeficiency virus 2

HIV-2

Target: Human CCR5

Preclinical

Preclinical

Phase 2

Phase 3

Approved

HCV

Target: Human CCR5

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Severe acute respiratory syndrome-related coronavirus

SARS-CoV-2

Target: Human CCR5

Preclinical

Preclinical

Phase 2

Phase 3

Approved